6 European Projects Found
Searched on 125080 European Projects
FINISHED
European AIDS Vaccine Initiative 2020 (EAVI2020)
Start date: Nov 1, 2015, End date: Oct 31, 2020,
HIV-1 is responsible for a global pandemic of 35 million people, and continues to spread at a rate of >2 million new infections/year. It is widely acknowledged that a protective vaccine would be the most effective means to reduce HIV-1 spread and ultimately eliminate the pandemic, while a therapeutic vaccine may help mitigate the clinical course of disease and lead to strategies of viral eradicati ...
Read Project
27
Partners Participants
FINISHED
European Research Infrastructures for Poverty Related Diseases (EURIPRED)
Start date: Nov 1, 2013, End date: Oct 31, 2017,
HIV/AIDS, Tuberculosis (TB) and Malaria alone account for more than six million deaths worldwide every year. Despite substantial efforts made in recent years, Poverty Related Diseases are still spreading. New therapeutic interventions are therefore urgently required to combat Poverty Related Diseases. The existence of a well-developed HIV/TB/Malaria infrastructure presents a prime opportunity to a ...
Read Project
18
Partners Participants
FINISHED
Novel tumor-selective lethal miRNAs for the treatment of head and neck cancer (MIRACLE)
Start date: Oct 1, 2013, End date: Oct 31, 2016,
...e synthesis of biochemical active miRNA (Biospring), (2) knowledge of drug formulations to deliver the therapeutic miRNA into humans (IC) and understanding the synthesis of complex drug formulations (Polymun), plus (3) in-depth knowledge of the therapeutic indication, e.g. H&N cancer (VUmc) and skilfulness in toxicity tests that are required for RNA based drug registration (LPT). We believe that t ...
Read Project
9
Partners Participants
FINISHED
First in Man Novel Anticancer Therapeutic based on Dependence Receptors Concept (HERMIONE-2MAN)
Start date: Sep 1, 2013, End date: Aug 31, 2016,
...2MAN project will pave the way to an outstanding & innovative approach of cancer treatment, offering great clinical and market potential. The consortium gathers 1 academic partner (CLB), 2 SMEs (NP & Polymun) and a non-profit organization (EORTC).
Read Project
5
Partners Participants
FINISHED
Combined Highly Active Anti-retroviral Microbicides (CHAARM)
Start date: Jan 1, 2010, End date: Jun 30, 2015,
This proposal is for a large scale collaborative project in which we propose both to develop novel microbicides directed against new intracellular targets and to investigate novel combinations of highly active anti-retroviral drugs which may be particularly effective as microbicides. Combinations may enhance efficacy but equally importantly will increase the genetic barrier to the development of r ...
Read Project
34
Partners Participants
FINISHED
EUROpean consortium on NEUTralising antibodies using gp41 (EURONEUT-41)
Start date: Jan 1, 2008, End date: Mar 31, 2014,
There is now an increasingly solid body of scientific evidence which demonstrates that the binding of small molecular weight compounds, peptides and antibodies (Abs) to fusion-intermediate conformations of gp41 leads to an inhibition of HIV cell entry. The principal aim of this project is to exploit this information by establishing a platform where gp41-derived vaccine candidates will be designed ...
Read Project
